Brief: Iterum Therapeutics Provides Business Update
13/02/2026 13:45
Feb 13 (Reuters) - Iterum Therapeutics PLC ITRM.O: ITERUM THERAPEUTICS PROVIDES BUSINESS UPDATE ITERUM THERAPEUTICS PLC - FDA RECOMMENDS TYPE C MEETING FOR ITERUM'S CLINICAL INVESTIGATION ITERUM THERAPEUTICS PLC: FDA RECOMMENDS TYPE C MEETING FOR PROPOSED CLINICAL INVESTIGATION FOR ORLYNVAH Source text: ID:nGNX6lVLWy Further company coverage: ITRM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity